Evidence map›Paper›PMID 27484504›Full record

ArticleJournal of clinical immunology2016

Phenotypic and Functional Comparison of Class Switch Recombination Deficiencies with a Subgroup of Common Variable Immunodeficiencies.

Daan J Aan de Kerk, Machiel H Jansen, Stephen Jolles, Klaus Warnatz, Suranjith L Seneviratne, Ineke J M Ten Berge, Ester M M van Leeuwen, Taco W Kuijpers

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Progressive B cell depletion in human MALT1 deficiency.Clinical and experimental immunology · 2021
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Daan J Aan de KerkDepartment of Pediatric Hematology, Immunology and Infectious Diseases, Academic Medical Center (AMC), Amsterdam, The Netherlands. d.j.aandekerk@amc.nl.
Machiel H JansenDepartment of Pediatric Hematology, Immunology and Infectious Diseases, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Stephen JollesDepartment of Immunology, University Hospital of Wales Heath Park Cardiff, Cardiff, UK.
Klaus WarnatzDepartment of Rheumatology and Clinical Immunology, University Medical Centre Freiburg, Freiburg, Germany.
Suranjith L SeneviratneDepartment of Immunology, Royal Free London NHS Foundation Trust, London, UK.
Ineke J M Ten BergeDepartment of Internal Medicine, AMC, Amsterdam, The Netherlands.
Ester M M van LeeuwenDepartment of Experimental Immunology, AMC, Amsterdam, The Netherlands.
Taco W KuijpersDepartment of Pediatric Hematology, Immunology and Infectious Diseases, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Academic Medical Center · NLRoyal Free London NHS Foundation Trust · GBUniversity Hospital of Wales · GBUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary antibody deficiencies (PADs) are the most common immunodeficiency in humans, characterized by low levels of immunoglobulins and inadequate antibody responses upon immunization. These PADs may result from an early block in B cell development with a complete absence of peripheral B cells and lack of immunoglobulins. In the presence of circulating B cells, some PADs are genetically caused by a class switch recombination (CSR) defect, but in the most common PAD, common variable immunodeficiency (CVID), very few gene defects have as yet been characterized despite various phenotypic classifications. Using a functional read-out, we previously identified a functional subgroup of CVID patients with plasmablasts (PBs) producing IgM only. We have now further characterized such CVID patients by a direct functional comparison with patients having genetically well-characterized CSR defects in CD40L, activation-induced cytidine deaminase (AID) and uracil N-glycosylase activity (UNG). The CSR-like CVID patients showed a failure in B cell activation patterns similar to the classical AID/UNG defects in three out of five CVID patients and distinct more individual defects in the two other CVID cases when tested for cellular activation and PB differentiation. Thus, functional categorization of B cell activation and differentiation pathways extends the expected variation in CVID to CSR-like defects of as yet unknown genetic etiology.

Indexed as

PhenotypeAdolescentAdultBiomarkersB-LymphocytesCommon Variable ImmunodeficiencyFemaleGenetic Predisposition to DiseaseHumansImmunoglobulin Class SwitchingImmunoglobulin GImmunoglobulin MImmunophenotypingLymphocyte ActivationMaleMiddle AgedBiomarkersImmunoglobulin GImmunoglobulin MB cellsclass switch recombination defectcommon variable immunodeficiencyPrimary antibody deficiencies

Identifiers

PMID27484504
PMCPMC5018261
OpenAlexW2479106986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.